In this CLE program, leading litigation and regulatory attorneys address the implications of the landmark mifepristone litigation for women’s health, life science companies, administrative law, and the future of healthcare in America.
Meet the people who help you navigate complex challenges in alignment with your goals.
Explore our legal capabilities and industry experience.
Discover insights and events in line with the issues that matter most to your business.
Learn how we’re advancing pro bono, sustainability, and a culture grounded in inclusion and respect.
65,800
Hours our lawyers gave to pro bono work in 2025, valued at more than $55 million
760
We partnered with 760 charities and nonprofits on pro bono work in 2025
Join a global team built on collaboration, excellence, and forward-thinking solutions.
When
Thursday, April 11, 2024
12-1 p.m. EDT
In this CLE program, leading litigation and regulatory attorneys address the implications of the landmark mifepristone litigation for women’s health, life science companies, administrative law, and the future of healthcare in America.